Consolidated Portfolio Review Corp’s British American Tobacco BTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-9,710
Closed -$515K – 93
2025
Q3
$515K Sell
9,710
-215
-2% -$11.7K 0.06% 264
2025
Q2
$470K Buy
9,925
+850
+9% +$37.6K 0.07% 268
2025
Q1
$375K Buy
+9,075
New +$357K 0.06% 266

Other funds holding BTI

Consolidated Portfolio Review Corp's BTI Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of British American Tobacco (BTI) in Q4 2025, closing a stake of 9,710 shares — an estimated $515K sold.

Consolidated Portfolio Review Corp first reported a position in BTI in Q1 2025 and held it in 3 quarters. The position peaked at $515K in Q3 2025. 826 funds tracked by Wall St. Rank hold BTI as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining British American Tobacco position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 9,710 British American Tobacco shares in Q4 2025, an estimated $515K.
  • Consolidated Portfolio Review Corp first reported a position in British American Tobacco in Q1 2025 and held it in 3 quarters.
  • Consolidated Portfolio Review Corp's British American Tobacco position peaked at $515K in Q3 2025.
  • 826 funds tracked by Wall St. Rank held British American Tobacco as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.